| Literature DB >> 34836366 |
Noemi Kiss1,2, Michael Hiesmayr2,3, Isabella Sulz2,4, Peter Bauer2,4, Georg Heinze5, Mohamed Mouhieddine2,3, Christian Schuh2,6, Silvia Tarantino2, Judit Simon1,2.
Abstract
Hospital length of stay (LOS) is an important clinical and economic outcome and knowing its predictors could lead to better planning of resources needed during hospitalization. This analysis sought to identify structure, patient, and nutrition-related predictors of LOS available at the time of admission in the global nutritionDay dataset and to analyze variations by country for countries with n > 750. Data from 2006-2015 (n = 155,524) was utilized for descriptive and multivariable cause-specific Cox proportional hazards competing-risks analyses of total LOS from admission. Time to event analysis on 90,480 complete cases included: discharged (n = 65,509), transferred (n = 11,553), or in-hospital death (n = 3199). The median LOS was 6 days (25th and 75th percentile: 4-12). There is robust evidence that LOS is predicted by patient characteristics such as age, affected organs, and comorbidities in all three outcomes. Having lost weight in the last three months led to a longer time to discharge (Hazard Ratio (HR) 0.89; 99.9% Confidence Interval (CI) 0.85-0.93), shorter time to transfer (HR 1.40; 99.9% CI 1.24-1.57) or death (HR 2.34; 99.9% CI 1.86-2.94). The impact of having a dietician and screening patients at admission varied by country. Despite country variability in outcomes and LOS, the factors that predict LOS at admission are consistent globally.Entities:
Keywords: competing risks; dietician; discharge; hospital; length of stay; mortality; nutrition; nutrition screening; survey; transfer
Mesh:
Year: 2021 PMID: 34836366 PMCID: PMC8624242 DOI: 10.3390/nu13114111
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Participant Flow.
Figure 2Proportion of outcomes 30 days after nutritionDay by country.
Figure 3Cumulative incidence graphs for global data and per groups of 10 countries (adjusted for length bias) including figure (a) for the global data and figure (b) for countries with n > 3000; figure (c) for countries with 1500 < n ≤3000; figure (d) for countries with 750 < n ≤ 1500.
Median length of stay by selected * nutrition-related baseline variables adjusted for length bias.
| Total | Time to Discharge | Time to Transfer | Time to Death | |
|---|---|---|---|---|
| Weight Δ in the last 3 months (prior to hospitalization) | ||||
| Lost weight | 7 (3–13) | 6 (3–12) | 10 (4–19) | 14 (7–26) |
| Idem (stayed the same) | 4 (3–9) | 4 (2–8) | 7 (3–14) | 11 (5–21) |
| Gained weight | 4 (3–8) | 4 (2–8) | 7 (3–13) | 9 (3–22) |
| Unsure | 7 (3–13) | 6 (3–12) | 10 (5–18) | 12 (5–21) |
| Missing | 6 (4–12) | 4 (2–9) | 10 (5–20) | 10 (6–20) |
| Nutrition risk screening at admission | ||||
| Not Screened | 7 (4–12) | 5 (3–10) | 10 (5–17) | 12 (7–22) |
| Screened | 5 (3–10) | 5 (3–9) | 8 (4–16) | 12 (6–24) |
| Missing | 5 (4–11) | 5 (4–11) | 3 (2–6) | 2 (2–2) |
| Dedicated nutrition care person (department) | ||||
| Yes | 5 (3–10) | 5 (3–9) | 8 (4–16) | 13 (6–24) |
| No | 7 (4–13) | 6 (3–11) | 9 (5–18) | 11 (5–22) |
| Nutrition team available (hospital) | ||||
| Yes | 6 (4–12) | 5 (3–10) | 10 (5–18) | 13 (7–24) |
| No | 5 (3–9) | 5 (2–9) | 7 (3–14) | 11 (5–20) |
| Dietician available | ||||
| Yes | 5 (3–10) | 5 (3–9) | 8 (3–15) | 12 (6–23) |
| No | 7 (4–12) | 5 (3–10) | 10 (5–18) | 13 (6–24) |
| Missing | 6 (3–11) | 5 (3–10) | 10 (5–19) | 12 (6–22) |
* Median length of stay for all baseline variables are available in the Supplementary Materials; outcomes are measured 30 days after nutritionDay.
Figure 4Median length of stay for all outcomes by country corrected for length bias.
Hazard ratios and confidence intervals for statistically significant * determinants of length of stay (based on multivariable global model **).
| Discharged | Transferred | Died in Hospital | ||||
|---|---|---|---|---|---|---|
| Variable | Increase LOS | Decrease LOS | Increase LOS | Decrease LOS | Increase LOS | Decrease LOS |
| Patient characteristics | ||||||
| Age (reference 61–70) | - | - | - | - | - | - |
| 18–30 | - | 1.18 (1.12–1.24) | - | - | 0.31 (0.14–0.71) | - |
| 31–40 | - | 1.15 (1.09–1.21) | - | - | 0.49 (0.29–0.85) | - |
| 41–50 | - | 1.10 (1.05–1.15) | - | - | - | - |
| 51–60 | - | 1.06 (1.02–1.10) | - | - | - | - |
| 71–80 | 0.92 (0.89–0.96) | - | - | 1.25 (1.10–1.43) | - | 1.40 (1.10–1.77) |
| 81–120 | 0.78 (0.74–0.82) | - | - | 1.77 (1.54–2.04) | - | 2.25 (1.78–2.84) |
| Male | - | - | - | - | - | 1.19 (1.03–1.39) |
| Affected Organs | ||||||
| Brain/nerves | 0.86 (0.82–0.91) | - | 1.35 (1.19–1.55) | - | - | - |
| Skeleton/bone/muscle | 0.86 (0.81–0.90) | - | 1.22 (1.07–1.39) | - | 0.62 (0.47–0.82) | - |
| Blood/bone marrow | 0.86 (0.80–0.93) | - | - | - | - | - |
| Skin | 0.87 (0.81–0.93) | - | - | - | - | - |
| Cancer | 0.91 (0.86–0.96) | - | - | - | - | 2.34 (1.88–2.90) |
| Infection | 0.86 (0.81–0.91) | - | - | - | - | 1.34 (1.04–1.73) |
| Eye/ear | - | 1.12(1.02–1.22) | - | - | - | - |
| Lung | 0.88 (0.85–0.92) | - | - | - | - | 1.83 (1.50–2.24) |
| Liver | 0.86 (0.81–0.91) | - | - | - | - | 1.90 (1.45–2.49) |
| Comorbidities | - | - | - | - | - | - |
| Diabetes I/II | 0.94 (0.91–0.97) | - | - | - | - | |
| Stroke | 0.90 (0.84–0.97) | - | - | - | - | - |
| Others | 0.96 (0.93–0.99) | - | - | 1.13 (1.01–1.27) | - | - |
| Setting characteristics | ||||||
| Regions (ref. Eur A) | ||||||
| American Region A | - | 1.10 (1.02–1.17) | - | 2.59 (2.06–3.26) | - | - |
| American Region B | 0.92 (0.85–0.99) | - | - | - | - | 1.82 (1.34–2.47) |
| Europe Region B/C | 0.86 (0.79–0.93) | - | 0.50 (0.30–0.83) | - | - | - |
| Japan | 0.80 (0.68–0.93) | - | 0.31 (0.23–0.43) | - | 0.46 (0.31–0.70) | - |
| Specialty (ref. Internal medicine) | - | - | - | - | - | - |
| Cardiothoracic surgery | - | - | - | - | 0.38 (0.15–0.95) | - |
| Ear Nose Throat (ENT) | - | - | - | - | 0.22 (0.07–0.69) | - |
| General surgery | - | 1.07 (1.00–1.14) | - | - | 0.54 (0.39–0.76) | - |
| Geriatrics | 0.67 (0.60–0.76) | - | - | - | 0.67 (0.49–0.91) | - |
| Gynaecology | - | - | - | - | 0.34 (0.13–0.94) | - |
| Long-term care | 0.72 (0.53–0.99) | - | 0.51 (0.29–0.91) | - | - | - |
| Orthopaedic surgery | - | - | - | - | 0.47 (0.23–0.97) | - |
| Psychiatry | 0.63 (0.45–0.87) | - | 0.43 (0.21–0.88) | - | 0.11 (0.02–0.70) | - |
| Nutrition-related characteristics | ||||||
| Dietician available | - | - | 0.77 (0.63–0.94) | - | - | - |
| Nutrition team available | 0.95 (0.91–1.00) | - | - | - | - | - |
| Weight Δ in the last 3 months (reference idem) | ||||||
| Lost weight | 0.86 (0.83–0.88) | - | - | - | - | 1.75 (1.40–2.18) |
| Unsure | 0.87 (0.80–0.93) | - | - | 1.47 (1.21–1.79) | - | 4.50 (3.35–6.05) |
| Missing | 0.83 (0.78–0.89) | - | - | 1.32 (1.13–1.54) | - | 2.88 (2.07–4.03) |
Gray indicates determinant type of the variables that follow * statistically significant at p < 0.001 ** complete cases analysis using Cox proportional hazards model with competing risks extension. Definitions: American Region A = Canada, United States of America; American Region B = Argentina, Brazil, Chile, Columbia, Dominican Republic, Ecuador, El Salvador, Mexico, Panama, Paraguay, Uruguay; Asia Pacific = Bangladesh, China, India, Korea, Malaysia, Philippines, Singapore, Thailand; Eastern Mediterranean Region = Egypt, Iran, Kuwait, Oman, United Arab Emirates; Europe Region A = Austria, Belgium, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany, UK, Greece, Israel, Italy, Luxembourg, Netherlands, Norway, Slovenia, Spain, Sweden, Switzerland, Portugal; Europe Region B/C = Albania, Bosnia and Herzegovina, Bulgaria, Estonia, Georgia, Hungary, Latvia, Lithuania, Poland, Romania, Russian Federation, Serbia, Slovakia, Turkey, Ukraine; Japan = Japan; Oceania = Australia, New Zealand.
Figure 5Nutrition-related determinants of length of stay (based on multivariable Cox proportional hazards competing risk country models).